New test may quickly detect early-stage lung cancer
Feb. 10, 2022
Peking University, February 10, 2022: Researchers at Peking University People’s Hospital in China have developed a rapid and reliable blood test to detect early-stage lung cancer.
A newly developed blood test may detect lung cancer as quickly as 90 minutes. Tek Image/Science Photo Library/Getty Images
Early detection of lung cancer has associations with better treatment options and survival rates, but current screening techniques for lung cancer often produce low accuracy results.
The novel noninvasive test, named Lung Cancer Artificial Intelligence Detector (LCAID), assesses the levels of lipid biomarkers in plasma samples. The high accuracy of this test suggests that it could be potentially deployed in combination with current screening techniques to improve the detection of early-stage lung cancer.
The study’s lead author Jun Wang, chief of the Department of Thoracic Surgery at Peking University Peoples Hospital, told Medical News Today: "The accuracy and high specificity of LCAID might help improve the detection and screening of lung cancer and consequently reduce unnecessary exposure to radiation and invasive diagnostic procedures. Notably, most patients with lung cancer included in this study were at Stage I, and over 90% of them were correctly classified by LCAID."
The research describing the development and validation of this new test appears in Science Translational Medicine.
Source: Medical News Today
